Hebei Jingye Medical Technology Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Hebei Jingye Medical Technology Co.,Ltd.

24 YRS

Hebei, China

CNY 20.6 Million

66600 m²

100-500 people

Main Products: Salicylic Acid / Aspirin

Hebei, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

Manufacturing

Total Employees

100-500 People

Plant Size

100 Acres

Total Annual Revenue

CNY 173.8 Million

Production Experience

24+ Years

MAIN
PRODUCTS

1/3

Salicylic Acid

CAS: 69-72-7

Packing: 25 KG/Paper Bag; 25 KG/Woven Bag

Lead Time: 14-30 days

Inquiry

1/1

Aspirin

CAS: 50-78-2

Packing: 25 KG/Woven Bag

Lead Time: 14-30 days

Inquiry

ABOUT US

Hebei Jingye Medical Technology Co.,Ltd.

Hebei Jingye Medical Technology Co., Ltd. is a high-tech pharmaceutical company based in China for the world. With a clear focus on the manufacture, research and development and providing services for cardiovascular and cerebrovascular preparations and bulk pharmaceutical chemicals, the company is committed to emerging to be the most competitive manufacturer of salicylic acid and aspirin. It owns 4 varieties of products and 6 others in stock, all of which belong to preparations and bulk chemicals for cardiovascular and cerebrovascular diseases with great market prospects. Founded in 1990, Jingye Medical Technology Co., Ltd. boasts advanced equipment, sophisticated technology and competent technical force. Owning to 28 years of unremitting efforts, the company has built its main products, Jingye-branded salicylic acid, medicinal salicylic acid and aspirin, to become well-known across the globe. Holding import & export licensees at hand, the company sells its products not only at home but also abroad. Its products enjoys 70% market share in China, and can be easily seen in the US, Russia, Britain, Germany, France and other European and American countries and a large number of Asian countries and regions. To make the pharmaceutical sector larger and more competitive, the company selected the Bioengineering and Pharmaceutical Industrial Park in Bohai New District of Cangzhou, a national technology development zone, as the location for its new plant. Covering an area of up to100 mu, the new facility is designed by Tianjin Pharmaceuticals Design Institute with a total investment of 350 million yuan.